HomeNDC LookupIngredients › Disopyramide Phosphate
📦 NDC / package directory — not a drug information page

Disopyramide Phosphate NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Disopyramide Phosphate products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

14
Package NDCs
16
Products
16
Active listings
0
Discontinued
8
Labelers
4
Strengths
4
Dosage forms
9
With NADAC pricing

By strength, form & labeler

NDC products by strength
DISOPYRAMIDE PHOSPHATE 100 mg/1 7
DISOPYRAMIDE PHOSPHATE 150 mg/1 6
DISOPYRAMIDE PHOSPHATE 1 kg/kg 2
DISOPYRAMIDE PHOSPHATE 50 kg/50kg 1
By dosage form
CAPSULE, GELATIN COATED 6
CAPSULE 5
POWDER 3
CAPSULE, EXTENDED RELEASE 2
Top labelers
Pfizer Laboratories Div Pfizer Inc 6
Dr. Reddy's Labratories Inc. 2
Mylan Pharmaceuticals Inc. 2
Teva Pharmaceuticals USA, Inc. 2
Archimica S.p.A. 1
Mayne Pharma Commercial LLC 1
PCAS FINLAND 1
Sumitomo Chemical Company, Limited 1

Browse records — 16 products

Drug / product Billing NDC NADAC / unit Status
Disopyramide Phosphate 50 kg/50kg POWDER Archimica · NDC 55512-0004-00 · 50 kg in 1 DRUM (55512-0004-0) 55512-0004-00 On market View →
Disopyramide Phosphate 100 mg/1 CAPSULE, GELATIN COATED Mylan · NDC 59762-0386-01 · 100 CAPSULE, GELATIN COATED in 1 BOTTLE (59762-0386-1) 59762-0386-01 $0.851 /unit · NADAC On market View →
Disopyramide Phosphate 1 kg/kg POWDER Sumitomo · NDC 68259-1304-01 · 50 kg in 1 CONTAINER (68259-1304-1) 68259-1304-01 On market View →
DISOPYRAMIDE PHOSPHATE 100 mg/1 CAPSULE Dr. · NDC 75907-0027-01 · 100 CAPSULE in 1 BOTTLE (75907-027-01) 75907-0027-01 $0.851 /unit · NADAC On market View →
DISOPYRAMIDE PHOSPHATE 100 mg/1 CAPSULE Mayne · NDC 51862-0095-01 · 100 CAPSULE in 1 BOTTLE (51862-095-01) 51862-0095-01 $0.844 /unit · NADAC Discontinued View →
Disopyramide Phosphate 100 mg/1 CAPSULE Teva · NDC 00093-3127-01 · 100 CAPSULE in 1 BOTTLE (0093-3127-01) 00093-3127-01 $0.851 /unit · NADAC On market View →
DISOPYRAMIDE PHOSPHATE 150 mg/1 CAPSULE Dr. · NDC 75907-0026-01 · 100 CAPSULE in 1 BOTTLE (75907-026-01) 75907-0026-01 $1.501 /unit · NADAC On market View →
DISOPYRAMIDE PHOSPHATE 1 kg/kg POWDER PCAS · NDC 51014-7863-00 · 45 kg in 1 DRUM (51014-7863-0) 51014-7863-00 On market View →
Disopyramide Phosphate 150 mg/1 CAPSULE Teva · NDC 00093-3129-01 · 100 CAPSULE in 1 BOTTLE (0093-3129-01) 00093-3129-01 $1.501 /unit · NADAC On market View →
Disopyramide Phosphate 150 mg/1 CAPSULE, GELATIN COATED Mylan · NDC 59762-0400-01 · 100 CAPSULE, GELATIN COATED in 1 BOTTLE (59762-0400-1) 59762-0400-01 $1.501 /unit · NADAC On market View →
Norpace disopyramide phosphate 150 mg/1 CAPSULE, GELATIN COATED Pfizer · NDC 00025-2762-31 · 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2762-31) 00025-2762-31 On market View →
Norpace disopyramide phosphate 100 mg/1 CAPSULE, GELATIN COATED Pfizer · NDC 00025-2752-31 · 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2752-31) 00025-2752-31 On market View →
Norpace disopyramide phosphate 100 mg/1 CAPSULE, GELATIN COATED Pfizer · NDC 00025-2752-31 · 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2752-31) 00025-2752-31 On market View →
Norpace disopyramide phosphate 150 mg/1 CAPSULE, GELATIN COATED Pfizer · NDC 00025-2762-31 · 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2762-31) 00025-2762-31 On market View →
Norpace CR disopyramide phosphate 100 mg/1 CAPSULE, EXTENDED RELEASE Pfizer · NDC 00025-2732-31 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0025-2732-31) 00025-2732-31 $4.141 /unit · NADAC Discontinued View →
Norpace CR disopyramide phosphate 150 mg/1 CAPSULE, EXTENDED RELEASE Pfizer · NDC 00025-2742-31 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0025-2742-31) 00025-2742-31 $4.906 /unit · NADAC Discontinued View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.